Contact Us
Drug Search Results
More Filters [+]

LZM-009

Alternative Names: lzm-009, lzm 009, lzm009, LZM009,recombinant humanized anti-PD-1 monoclonal antibody for injection
Latest Update: 2021-11-16
Latest Update Note: News Article

Product Description

LZM-009 is being developed by Livzon Group for the treatment of patients with Relapsed or Refractory T-Cell Lymphoma. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT04712864?term=LB-1901&draw=2&rank=1)

Mechanisms of Action: PD-1 Inhibitor

Novel Mechanism: No

Modality: Antibody

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Livzon Group
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for LZM-009

Countries in Clinic: China

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Oncology Unspecified

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
CTR20200784

P2

Recruiting

Oncology Unspecified

None

Recent News Events

Date

Type

Title

11/16/2021

News Article

 Bright Peak Therapeutics Licenses Rights to Livzon's Anti-PD-1 Antibody LZM009 to Develop Novel PD-1 Targeted Immunocytokines

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions